Author:
Wizemann A.,Wizemann V.,Ebinger G.
Reference9 articles.
1. Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms Prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663.
2. Moncada S, Vane JR (1977) The discovery of prostacyclin — a fresh insight into arachidonic acid metabolism. In: Kharasch N, Fried J (eds) Biochemical aspects of Prostaglandins and thromboxanes. Academic Press, New York, p 155.
3. Moncada S, Higgs EA, Vane JR (1977) Human arterial and venous tissue generate prostacyclin (Prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1:18.
4. Moncada S, Vane JR (1979) Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 300:1142.
5. Armstrong JM, Lattimer N, Moncada S, Vane JR (1978) Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1α with those of Prostaglandin E2 in rats and rabbits. Br J Pharmacol 62:125.